-
Symbol
-
LXEO on Nasdaq
-
Investment type
-
Equity / Common Stock ($0.0001 par value) (the "Shares")
-
Latest Disclosed Shares Owned
-
2,765,381 shares
-
Security Ownership %
-
3.8%
Longitude Capital Partners IV, LLC ownership in Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO)
14 Nov 2025 - Longitude Capital Partners IV, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,765,381 shares of Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO).
This represents 3.8% ownership of the company.
This is the first filing by Longitude Capital Partners IV, LLC disclosing ownership of Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO).